Burjeel Holdings’ FY’23: Revenue Up by 16%,EBITDA Increases 18%

Abu Dhabi, United Arab Emirates, 6 March 2024: Burjeel Holdings PLC (“Burjeel” or “the Group”), a leading super-specialty healthcare services provider in MENA listed on the Abu Dhabi Securities Exchange (“ADX”) (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced its financial results in accordance with International Financial Reporting Standards (IFRS) for the twelve-month period ended 31 December 2023.

Strong Momentum on Strategic Priorities

Burjeel Holdings saw remarkable progress on its strategic ambitions to ramp up the Group’s high-growth assets, expand its healthcare infrastructure and drive patient yield through the provision of highly specialized complex care. The Group maintains its focus on the expansion of its medical network and enhancing operational efficiency through economies of scale and continued digitization. Over the next two years, Burjeel plans to open one hospital in Dubai, day surgery centers in Al Ain and Al Dhafra regions, as well as one medical center in Abu Dhabi.